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Optogenetics has been enthusiastically pursued
in recent neuroscience research, and the causal rela-
tionship between neural activity and behavior is
becoming ever more accessible. Here, we estab-
lished knockin-mediated enhanced gene expression
by improved tetracycline-controlled gene induction
(KENGE-tet) and succeeded in generating transgenic
mice expressing a highly light-sensitive channelrho-
dopsin-2 mutant at levels sufficient to drive the
activities of multiple cell types. This method requires
two lines of mice: one that controls the pattern of
expression and another that determines the protein
to be produced. The generation of new lines of
either type readily expands the repertoire to choose
from. In addition to neurons, we were able to manip-
ulate the activity of nonexcitable glial cells in vivo.
This shows that our system is applicable not only to
neuroscience but also to any biomedical study
that requires understanding of how the activity of a
selected population of cells propagates through the
intricate organic systems.
INTRODUCTION
There are two main approaches that one can take to understand
how a complex biological system composed of numerous cells
operates. One approach is to record the activities of as manycells as possible and compare these with the behavior of the
entire system. By nature, this approach is a correlation study,
and the causal relationship of the cells’ activities and the
behavior could only be estimated. The other approach is to
actively manipulate the cells’ activities and observe how such
perturbation influences the system’s behavior. Light-sensitive
proteins have recently gained recognition because they can be
used to control the cells’ activities by use of light when it is
expressed in cells (Nagel et al., 2003; Boyden et al., 2005). The
advantage of this method is that, if the expression can be
targeted, the physiological role of a selected population of cells
in a complex system can be readily assessed.
The quickest way of applying this method is to use viruses, but
this approach has problems in the reproducibility of expression
patterns and levels. Therefore, we chose to use a transgenic
approach, which allows stable expression. We also avoided
the conventional transgenic approach, in which separate lines
of animals for each promoter-protein combination are gener-
ated, because this approach seemed too laborious and because
obtaining a line with sufficiently high expression levels would not
be trivial.
We instead used a bigenic approach involving a tet-inducible
promoter system (Gossen et al., 1995). We generated or re-
ceived transgenic mice, each with a cell type-specific promoter
driving a tetracycline-controlled transcriptional activator (tTA)
expressing allele. We also generated transgenic mice with the
tTA-dependent promoter (tetO) driving the expression of chan-
nelrhodopsin-2 (ChR2), a blue light-gated, nonselective, cation
channel (Boyden et al., 2005; Nagel et al., 2003). Once equipped
with both sets, we had only to perform crosses between mice
from the two sets to obtain animals expressing ChR2 in a wideCell Reports 2, 397–406, August 30, 2012 ª2012 The Authors 397
Figure 1. tetO-ChR2(C128S)-EYFP Mice
(A) Actb gene structure and insertion site of tetO-ChR2(C128S)-EYFP. The Actb gene consists of 6 exons (rectangles), and the tetO-ChR2(C128S)-EYFP
polyA cassette (yellow) is inserted just downstream of the polyadenylation signal of Actb gene. AATAAA is a polyadenylation signal.
(B) BAC transgenic strategy. Modified clone RP23-289L7 contains the Actb gene followed by a tetO-ChR2(C128S)-EYFP cassette. RP23-239L7 contains
the Fscn1 (filled box, left) and the Fbxl18 (filled box, right) genes.
(C) Knockin strategy. The tetO-ChR2(C128S)-EYFP cassette is inserted into the same site by homologous recombination.
(D) Cell type-specific induction of ChR2(C128S)-EYFP. tTA is expressed under the control of cell type-specific promoters. tTA transactivates the tetO promoter,
and the ChR2(C128S)-EYFP fusion protein is induced in a cell type-specific manner.
See also Figure S1.variety of selected cell populations. While ChR2 induction can
be turned off by administration of doxycycline, we used the
system solely to achieve cell-type specificity and amplification
of transgene induction.
We previously attempted to use the tTA-mediated gene induc-
tion system to achieve specific and sufficient ChR2 expression.
aCaMKII-tTA mice (Mayford et al., 1996) were crossed with mice
having a bidirectional tTA-dependent promoter (bitetO) driving
both ChR2-mCherry and a halorhodopsin (HaloR; a yellow
light-driven chloride pump)-EGFP fusion gene that we generated
(line BTR6) (Chuhma et al., 2011). The bigenic line, aCaMKII-
tTA::BTR6, exhibited sparse ChR2 expression in striatal medium
spiny neurons, which enabled us to conduct a connectome anal-
ysis (Chuhma et al., 2011). However, even though tTA was
expressed under the control of the well-known aCaMKII pro-
moter, the line hardly showed any ChR2 expression in the hippo-
campus or dorsal cortex. We have found similarly poor induction
using other combinations, indicating a need for an improved
system. Here we report on technical improvements that were
made to overcome this limitation of the conventional tTA-
mediated gene induction.
RESULTS
Improvement of the tet System
When using the tet system to achieve cell type-specific expres-
sion of ChR2, the repertoire of bigenic transgenic lines can be
expanded by increasing the numbers of either the tTA or the
tetO lines coding variants of ChR2. However, the tet system
often fails to produce sufficient expression in the expected
pattern or cellular targets. It is likely that, even with sufficient
tTA being expressed, the inserted tetO promoter locus may be
influenced by suppressor sequences nearby or may not be
readily accessible by the increased promoter DNA methylation398 Cell Reports 2, 397–406, August 30, 2012 ª2012 The Authorsor by the repressive histone modifications (Oyer et al., 2009;
Zhu et al., 2007). We anticipated that knocking in the tetO-
ChR2 gene at or near a housekeeping gene would lead to high
levels of transactivation because: (1) we empirically noticed
that the levels of tet system-mediated gene induction were
extremely high when tetO was knocked into the genome by
embryonic stem (ES) cell homologous recombination (Tanaka
et al., 2010), and (2) the transcriptional machinery is likely to be
accessible to the genome around the housekeeping gene, which
may permit binding of tTA to tetO site in any cell type (Palais
et al., 2009).
Based on the above reasoning and observations, we targeted
transgene insertion just downstream of the b-actin gene polya-
denylation signal and generated tetO-ChR2(C128S)-EYFP
knockin mice by ES cell homologous recombination (knockin;
Figures 1A, 1C, and S1). We chose the C128S mutant of ChR2
because it has a much higher effective sensitivity to light than
does the wild-type ChR2 due to the very slow dark recovery
(Berndt et al., 2009), which potentially allows stimulation of cells
with even modest levels of expression. The activation/deactiva-
tion rates with blue light are slow (ton = 20 and 1.7 ms, toff = 108 s
and 10 ms, for ChR2(C128S) and wild-type ChR2, respectively)
(Berndt et al., 2009); however, toff can be accelerated up to
57 ms by yellow light pulse with the maximum light intensity
achievable in our setup. As ChR2(C128S) allows continuous,
heightened activity of the expressed cell with minimal blue
light illumination, it can be used to mimic the elevated neural
activity (upstate), which is often observed in in vivo recordings
(Steriade et al., 1993). If the cell’s action potential firing rate
does not accommodate, the light-stimulated cell expressing
ChR2(C128S) can potentially fire consecutively at its maximum
capacity.
To determine whether the method of inserting the transgene
(homologous recombination versus random insertion) has any
Figure 2. Superiority of the Knockin-Mediated ENhanced Gene Expression by Improved tet System over Other Transgene Expression
Methods
Five cell type-specific tTA lines (columns) were crossed with three tetO lines (rows) coding light-sensitive protein (ChR2 and/or HaloR) and a fluorescent
protein (EYFP or EGFP) fusion. Top, middle, and bottom row panels show EYFP immunohistochemistry of tissues from mice crossed with tetO-ChR2(C128S)-
EYFP knockin mice (knockin), EYFP frommice crossed with tetO-ChR2(C128S)-EYFP BAC transgenic mice (BAC transgenic), and EGFP frommice crossed with
bitetO transgenic line (BTR6; transgenic). tTA lines specific for neurons (aCaMKII and orexin promoter; first and second columns, respectively), astrocytes
(Mlc1 promoter; third column), oligodendrocytes (PLP promoter; fourth column), and microglia (Iba1 promoter; fifth column) were used. The first, fourth, and
fifth columns are from tissues of the hippocampus, the second column is from the lateral hypothalamus, and the third column is from the cerebellar lobe. Note
that crossing of the cell type-specific tTA lines with tetO knockin mice (KENGE-tet system) provided the highest levels of gene expression in all cell types.
Scale: 200 mm.
See also Figure S2.effect on tTA-mediated transcription, we also generated a bacte-
rial artificial chromosome (BAC) transgenic mouse, in which the
identical cassette was inserted into the identical site down-
stream of the b-actin gene within the BAC (BAC transgenic;
Figure 1B). The insertion site of the modified BAC in the mouse
genome is random, but, as the tetO-ChR2(C128S)-EYFP trans-
gene is flanked by a large fragment of genomic DNA from the
site near the b-actin gene, the chromosomal positional effect, if
present, is expected to be small. As a case for random insertion
of the sequence starting only from the tetO promoter, we used
bitetO-ChR2-mCherry and HaloR-EGFP transgenic mice (line
BTR6; transgenic; (Chuhma et al., 2011)).
These tetO lines were crossed with cell type-specific tTA lines
(Figure 1D), and the degree of tTA-mediated transcription was
examined by immunohistochemistry on fluorescent proteins
(Figure 2). First, the tetO lines were crossed with the aCaMKII-
tTA mice (Mayford et al., 1996), in which case aCaMKII promoter
activity should produce tTA expression in most pyramidal cells
in the hippocampus. In the case of the tetO conventional
transgenic mice (BTR6), tTA-mediated gene expression, as
assessed by the EGFP immunohistochemistry, was sparse in
the hippocampal CA1, and no expression was found in thedentate gyrus (Figure 2, bottom). The poor expressions of
HaloR-EGFP might be explained by the aggregate formation of
this protein because the original version of the HaloR-EGFP
that we used was often found to aggregate easily. However,
we failed to detect even themRNA of HaloR-EGFP in the dentate
gyrus, indicating that tTA-mediated transactivation was limited
in tetO conventional transgenic mice. In the case of the tetO
BAC transgenic mice, EYFP induction in CA1 was dramatically
increased, but expression in the dentate gyrus was still not
observed. tetO knockin mice exhibited EYFP induction in both
CA1 and the dentate gyrus, an expression profile consistent
with that of aCaMKII promoter activity (Mayford et al., 1996).
Crosses with other tTA lines, specific for orexin neurons
(Orexin-tTA; A.Y., unpublished data), astrocytes (Mlc1-tTA; Ta-
naka et al., 2010), oligodendrocytes (PLP-tTA; Inamura et al.,
2012), and microglia (Iba1-tTA; Figure S2), exhibited the same
tendency: no/rare induction of EGFP in the tetO transgenic,
moderate/high levels of EYFP expression in the tetO BAC trans-
genic, and the highest levels of expression in the tetO knockin
mice. These observations indicated that both the genomic posi-
tion of the tetO cassette and the method of genomic insertion
were critical in gaining efficient gene induction. As the transgeneCell Reports 2, 397–406, August 30, 2012 ª2012 The Authors 399
Figure 3. ChR2(C128S)-EYFP Expression Is High Enough to Permit Light-Evoked Responses in Multiple Cell Types
(A) Various promoter-tTA lines were crossed with our tetO-ChR2(C128S)-EYFP knockin mice.
(B) Anatomical location of the cells recorded in (C–H).
(C) GAD67-tTA drove ChR2(C128S)-EYFP expression in a subset of Purkinje cells (green) in the cerebellum. Using acute brain slices, cells with green fluorescence
were visually selected and recorded in whole cell patch clamp mode with Alexa 594 in the pipette solution to confirm their identity from morphology (red).
Illumination of blue light evoked inward current and yellow light resulted in cessation of this current (middle column; in voltage-clamp; Vh = 85 mV). Action
potential firing was observed when recorded in current-clamp mode (right column; K+-based internal solution; 5 traces overlaid).
(D and E) Htr5B-tTA drove ChR2(C128S)-EYFP expression in medial habenula and inferior olive neurons. In both cases, the inward current activated by the
illumination was often sufficient to produce action potential firing.
(F–H) ChR2(C128S)-EYFP expression could also be driven in nonexcitable glial cells (astrocytes, oligodendrocytes, and microglia), and light-evoked current
responses could be observed. Light-evoked depolarization was relatively small in astrocytes (cerebellar Bergman glial cells), likely due to the low input resistance
and the lack of major voltage-dependent conductances.
See also Figures S2, S3, and S4.insertion would occur randomly in conventional transgenic
approach, it is possible to obtain ubiquitous high expression
by pure chance. However, by knocking in the tetO cassette
downstream of the b-actin gene, we have established the
Knockin-mediated ENhanced Gene Expression by improved
tetracycline-controlled gene induction (KENGE-tet) system for
reliably generating transgenic mice with light-responsive cells.400 Cell Reports 2, 397–406, August 30, 2012 ª2012 The AuthorsRepertoire of Optogenetic Control of Neurons
and Glial Cells
As we found that the KENGE-tet strategy greatly improved the
expression level of the transgene, we next sought to determine
whether the expression was high enough to drive cellular activity
upon illumination (Figures 3C–3E). Use of the existing cell type-
specific tTA lines, along with the tetO knockin mice, enabled
us to construct a repertoire of mice expressing ChR(C128S)-
EYFP in a variety of tissues and cell types. We first prepared
bigenic mice (P14-21) with a neuron-specific promoter driving
tTA and performed whole cell patch-clamp recordings on cells
expressing EYFP. Light-evoked responses of ChR2(C128S)
from Purkinje cells in the cerebellum (with GAD67-tTA-mediated
induction; generated by J.N. and Y.Y., see Extended Experi-
mental Procedures), neurons in the medial habenula (serotonin
receptor 5B-tTA [Htr5B-tTA]); Figure S3), and neurons in the infe-
rior olive (Htr5B-tTA) were examined. In all cases, inward current
(74.1 ± 49.7 pA, 16.1 ± 7.1 pA, and 29.9 pA in Purkinje cells,
medial habenula neurons, and inferior olive neurons positive
for EYFP; n = 4, 4, and 1, respectively) was evokedwith blue light,
and yellow light shut down the current, a feature of the bistable
switch of ChR2(C128S). In most cases, the amount of photocur-
rent was sufficient to produce action potential firing in current
clampmode. Using slices from older animals (P30), we observed
that the photocurrent was an order of magnitude larger in
Purkinje cells positive for EYFP (Figure S4; P17–20, 52.9 ±
21.6 pA, P30, 582.7 ± 178.1 pA; n = 6 and 3, respectively). This
implies that the ChR2(C128S)-EYFP expression progressively
increases with age allowing robust control of cells’ activity, espe-
cially in adult animals used for most in vivo studies. We also
generated bigenic mice with a glia-specific promoter driving
tTA and recorded light responses from the Bergmann glial cells
(astrocytes) in the cerebellum (Mlc1-tTA) (Figure 3F), from oligo-
dendrocytes in the hippocampal alveus (PLP-tTA) (Figure 3G),
and from microglia in the caudal cortex (Iba1-tTA) (Figure 3H).
Light-evoked current could also be induced in these glial cells,
which are traditionally categorized as nonexcitable (104.5 ±
59.0 pA, 94.6 ± 35.7 pA, and 11.5 ± 2.4 pA for Bergmann glial
cells, oligodendrocytes, and microglia positive for EYFP; n = 5,
6, and 5, respectively). The depolarization in astrocytes was rela-
tively moderate, likely due to the low input resistance of these
cells and the absence of major voltage-gated conductances.
In Vivo Optogenetic Control of Neurons
The benefit of our transgenic method is that we can obtain
consistent ChR2(C128S)-EYFP expression patterns and levels
within a given line of bigenic animals. In vivo experiments espe-
cially are often faced with variability between individual animals,
and virus-mediated ChR2 expression would only add to the
complexity of interpretation of the data, as the extent and local-
ization of infection would inevitably vary between trials. The
choice of the modified ChR2(C128S), which exhibits slow inacti-
vation, seemed also advantageous in in vivo studies, as pro-
longed activation of cells is possible with only brief illumination
with blue light, which should minimize the toxicity caused by
the illumination itself. We took advantage of our system for the
stable expression of ChR2(C128S)-EYFP and studied the light-
evoked responses of neurons in vivo and the effect on the
behavior of the animal.
For this study, we crossed a well-established tTA line, the
aCaMKII-tTA line, with the tetO-ChR2(C128S)-EYFP knockin
line that we generated (Figure 4A). The bigenic mice showed
strong expression of ChR2(C128S)-EYFP in the hippocampal
pyramidal neurons (Figure 2). Therefore, we first examined the
effect of ChR2(C128S) activation on the field potential in thehippocampal CA1 area by in vivo recording using a microelec-
trode attached to an optical fiber (Figure 4A). Incidents of
multi-unit and ripple-like synchronous events were prominently
increased in response to blue light illumination (500-ms pulses,
every 1 min; Figure 4B). As yellow light was not applied to rapidly
terminate the ChR2(C128S) activation, the increase in the event
frequency lasted for tens of seconds, but the event frequency
came back close to the baseline within 1min (Figure 4B, bottom),
which allowed repetitive stimulation. These data show that the
effect of the light stimulation on neuronal activity was clear and
consistent (Figure 4B, n = 9 recordings from three animals).
To determine whether such manipulation of cell activity was
powerful enough to cause behavioral responses, we implanted
an optical fiber in position for illuminating the left, dorsal hippo-
campal CA1 area and connected it to a laser light source via
an optical swivel to avoid tangling of the fiber from the free-
moving mouse (Figure 4C). The mouse was kept in its home
cage, and the mouse tended to stay in one location prior to the
illumination. However, upon illumination (500-ms pulses, every
1 min), an increase in the mouse’s locomotion activity occurred,
along with an emergence of behavior resembling thigmotaxis.
Seeking behavior, as well as digging of the bedding, was also
observed. Interestingly, such behavior started with a delay of
approximately 100 s, which contrasts with the direct ChR2 acti-
vation of neurons in the motor cortex, which causes muscle
movements almost immediately upon illumination (Ayling et al.,
2009; Hira et al., 2009). This suggests that the light stimulation
in our case was not simply evoking motor behavior; some sort
of cognitive response prior to the motor behavior could also
have been evoked. Even though light pulses were periodically
applied, the increase in locomotion activity gradually settled,
which correlate with the moderate rundown of light-evoked
neuronal activity with repetitive stimuli (Figure 4B). However,
the increase was still observable after 30 min from the onset of
illumination.
Themousewas sacrificed at 30min after the initiation of illumi-
nation and processed for histochemical analyses (Figure 4D). It
has been reported that increase in c-fos is related to cell activity
(Schoenenberger et al., 2009; Sheng and Greenberg, 1990), and
by using in situ hybridization, we revealed that unilateral 30 min
activation of ChR2(C128S) in the hippocampal CA1 region re-
sulted in bilateral increase in c-fos induction in neurons of the
hippocampus. It is possible that diffuse light from the optic fiber
directly stimulated the cells in the contralateral hippocampus;
however, even though ChR2(C128S) was also expressed in the
dorsal cortex through aCaMKII promoter activity, neurons in
this region did not show significant increases in c-fos. Therefore,
it is likely that excitation of neurons initiated unilaterally by illumi-
nation could have spread to the contralateral region by neural
activity subsequent to the direct stimulation. In the wild-type
mouse, no increase in c-fos expression or change in behavior
was observed with illumination through an optic fiber placed
similarly, showing that the neural activity was caused not by
the possible heat from or the endogenous response to the
illumination.
In contrast to the most previous transgenic approach in
which only a weak expression was achieved in a small subset
of cells, our KENGE-tet system achieves robust and strongCell Reports 2, 397–406, August 30, 2012 ª2012 The Authors 401
Figure 4. In Vivo Manipulations of Neurons and Glial Cells
(A) ChR2(C128S)-EYFP was expressed in hippocampal CA1 neurons by using the aCaMKII-tTA line. Dorsal left hippocampus was illuminated with blue light
pulses (500 ms pulses, every 1 min for 20–25 min) through an optical fiber inserted into the brain, and neuronal activity was measured by an accompanying
microelectrode.
(B) In vivo extracellular recordings of multi-unit and ripple-like activity of hippocampal neurons from an anesthesized transgenic mouse fixed under a stereotaxic
apparatus. Representative three traces before and after illumination aremagnified in themiddle panels. (bottom left) Peri-stimulus time histogram of the ripple-like
events from the example recording shown on top. Summary of the frequencies of ripple-like events during the 2 s leading up to (Control) and during the 2 s
following (Light) the light illumination are shown in the bottommiddle panel (n = 9 recordings from 3 animals; *p < 0.05, paired t test). (bottom right) Half decay time
of the ripple-like event frequency from the stimulus onset. Error bars: SEM.
(C) A photo of a freely moving mouse in its home cage with an optical fiber inserted into its brain close to the hippocampus (top left). Representative data of the
tracking of the head position (1 s intervals; bottom) during the 6min period prior to (Control) and the 6min period after (Light) the onset of a blue light stimulus train
(500 ms pulses at 1 min intervals). Locomotion velocity is plotted against time (bin width = 10 s; top right). Blue bars on top represent the timing of the light stimuli.
Bottom left panel shows the summary of the total travel distance during the 25 min after the initiation of light illumination train (n = 2 and 3 for transgenic and wild
mice, respectively; *p < 0.05, Student’s t test).
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ChR2(C128S)-EYFP expression. The above data demonstrate
that the expression is high enough that consistent changing of
the neuronal firing is possible and artificial manipulation of the
circuit can be strong enough to manifest in behavioral response
and in c-fos expression.
Optogenetic Manipulation of Glial Cells
Stimulation of neurons is often realized by using extracellular
electrodes in electrophysiological studies, but what is often
overlooked is that such stimulation inevitably stimulates the
nearby glial cells as well. To understand how glial cells interact
with neurons and participate in information processing in the
brain, specific stimulation of glial cells is desirable. To this end,
optogenetic manipulation of glial cell activity would be ideal;
however, we were uncertain whether current injection through
ChR2(C128S) would be sufficient to change glial cell activity
status. Depolarization by current injection through ChR2(C128S)
by itself is not surprising as any cell should react in this way
(Figures 3F and 3G). Therefore, we used our astrocyte-specific
ChR2(C128S)-EYFP-expressing mice, the Mlc1-tTA::tetO-
ChR2(C128S)-EYFP knockin mice, and examined whether light
stimulation could promote c-fos mRNA induction in astrocytes
(Figure 4, right).
When studying glial cells, one needs to remember that these
cells are very sensitive to injury. For example, just the insertion
of an optical plastic fiber resulted in gliosis around the fiber
and blue light illumination resulted in c-fos induction in glial cells
beneath the fiber in wild-type mice, which have no expression of
ChR2(C128S)-EYFP (data not shown). It is possible that local
heat produced by the illumination (Yizhar et al., 2011) could
have induced the c-fos expression in the injured glial cells
(Dragunow et al., 1989). This result indicates that surgical oper-
ation should be avoided when studying the physiological roles of
glial cell activity; therefore, the use of transgenic expression of
ChR2 is preferred over virus mediated gene transfer. Our choice
of themodified ChR2, ChR2(C128S). was also ideal because this
ChR2 mutant is highly sensitive to light; therefore, the chance of
stimulating this ChR2 variant through the skull without optical
fiber insertion was high.
An optical plastic fiber was placed on top of the skull and fixed
with dental cement, and the brain was illuminated only through
the skull (Figure 4E). Such manipulation alone did not produce
any injury to the brain or c-fos induction (data not shown). The
induction of c-fos mRNA in cortical astrocytes was confirmed
at 30 min after the onset of illumination (500-ms pulses, every
10 s; Figures 4G and 4H). c-fos mRNA induction in astrocytes
was never observed in wild-type mice after illumination through(D) ChR2(C128S)-mediated unilateral activation of CA1 neurons resulted in c-fos
(E) Astrocytic ChR2(C128S)-EYFP expression was induced by using the Mlc1-tTA
on top of the skull. Light was sent through only one of the two fibers.
(F) Cortical astrocytes, which were labeled by in situ hybridization to GLAST mR
EYFP in astrocytes.
(G) Illumination through the skull was able to induce c-fos mRNA expression on
expression was observed in the contralateral side (right). The medial region of th
wild-type or in mice not stimulated with light, thus, this expression was endog
activation.
(H) The c-fosmRNA positive cells stimulated by light were found to express GLAS
See also Figure S4.the skull, and induction was reproducibly observed in the bigenic
mice, indicating that this manipulation is specific. We also
checked the expression of c-fms mRNA, which gets increased
in activated microglial cells, and found that the expression level
was not increased surrounding the operated and illuminated
area (data not shown). This confirms that our light illumination
protocol itself did not induce specific damage to the brain tissue.
Our research shows that c-fos induction in astrocytes is
manipulable by optogenetics. Two recent studies showed opto-
genetic tool expression either in cultured astrocytes (Li et al.,
2012) or in astrocytes in vivo using viral delivery of the transgene
(Gourine et al., 2010); however, our method is unique, as whole
animals expressing ChR2(C128S) were obtained, allowing low-
invasiveness in vivo experiments. We have yet to understand
the mechanistic pathway leading from ChR2(C128S)-mediated
current influx to c-fos induction; however, the results show that
ChR2(C128S) activation could be used as a tool to specifically
manipulate astrocyte activity and the trace of manipulation can
be pursued by c-fos histochemistry.
DISCUSSION
Our initial attempts, as well as those of some of our colleagues,
to express ChR2 in a cell type-specificmanner at sufficiently high
levels to accomplish optogenetic manipulation of cell activity
using the transgenic approach have largely failed because
achievement of both specific and abundant expression was diffi-
cult. We have provided a solution to these conflicting require-
ments by using the improved KENGE-tet system. Specificity in
this system was attained by preparing a panel of tissue-specific
tTA lines, which allow cell type-specific expression in various cell
types. It has also been reported that the bipartite tet system can
amplify the level of transgene expression much more than direct
connection of the cell type-specific promoter to the transgene
(Arenkiel et al., 2007; Dhawale et al., 2010; Tomita et al., 2009;
Wang et al., 2007). In addition, knocking in our transgene,
ChR2(C128S)-EYFP, into a locus just downstream of b-actin
allowed sufficiently high induction for light responses.
The keys to our success of achieving high levels of gene induc-
tion by the KENGE-tet system were that: (1) the tetO was in-
serted to the genome as ‘‘knockin’’ and (2) the targeted locus
of the ‘‘knockin’’ was strategically selected. TetO mice gener-
ated by conventional plasmid transgenic approach would cause
transgene to insert in more or less random locations and tTA-
mediated gene induction in these mice often fails presumably
due to chromosomal position effects. We have already shown
in our previous study that tetO knockin yielded a high level ofmRNA induction bilaterally in both CA1 and dentate gyrus neurons.
line. To avoid injury-induced glial cell activation, the optical fibers were placed
NA (right), expressed EYFP (left), confirming the expression of ChR2(C128S)-
ly on the ipsi-lateral side (left), to which the light stimulus was given, and no
e cortex also expressed c-fos but such c-fos expression was also observed in
enous to the mice kept in our environment and not related to ChR2(C128S)
T mRNA, indicating that c-fos was induced in astrocytes. Scale bars: 200 mm.
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transactivation (Tanaka et al., 2010). In the current study, to
avoid the chromosomal position effects as much as possible,
genomic loci where the tetO promoter is activatable by the
tTA produced were searched. Previous studies have reported
that several loci, including the TIGRE locus (chr9, between
AB124611 and Carm1 genes) (Zeng et al., 2008), the LC-1 locus
(chr6, between Vmn1r33 and Vmn1r34 genes) (Scho¨nig et al.,
2011), and the HPRT locus (chr X) (Palais et al., 2009), provide
high tTA-mediated transcription when the tetO promoter is in-
serted. HPRT is generally regarded as a housekeeping gene,
motivating us to select another housekeeping gene, in this
case the gene for b-actin, for our gene targeting.
Once the targeted locus was selected, the BAC transgenic
strategy could be used to avoid a chromosomal position effect
(Scho¨nig et al., 2011). However, we assumed that tetO knockin
by ES cell homologous recombinationwould yield an even higher
level of transactivation than did the BAC transgenic strategy,
according to our experience with tetO knockin mice (Tanaka
et al., 2010). In the current study, we performed a direct compar-
ison between BAC transgenic and knockin approaches, and we
showed that the knockin of tetO into downstream of house-
keeping gene provided improvement to the tet system, although
the underlying mechanism of the enhancement of expression
was not made clear. We do need to note that in some cases
where the endogenous promoter activity is extremely high,
such as the orexin and PLP promoters, abundant tTA expression
levels are attained. In such cases, BAC transgenic approachwith
tetO inserted downstream of house-keeping gene within BAC
provides high enough levels of ChR2 (Figure 2) to trigger
photocurrents (data not shown). However, many endogenous
promoters that are specific to a certain population of cells usually
do not have such a high activity, and, in such case, only low to
moderate tTA levels could be attained, resulting low levels of
ChR2 induction. According to numbers of trials that we tested,
only the tetO knockin strategy, the KENGE-tet system, reliably
produced high levels of gene induction.
In addition to our improved KENGE-tet system for
ChR2(C128S)-EYFP expression, there are two other genetic
approaches to the induction of cell type-specific ChR2 expres-
sion in mice published to date: the ChR2 BAC transgenic
approach (Ha¨gglund et al., 2010; Zhao et al., 2011) and Cre-
loxP-mediated ChR2 expression (Ka¨tzel et al., 2011; Madisen
et al., 2012). Maintenance of ChR2 BAC transgenic mice is the
easiest among the three approaches, as only a single line of
mice needs to be kept. However, unlike the tet system approach,
simple BAC transgenic strategy lacks gene amplification
modules, and thus this strategy often requires strong endoge-
nous promoter activity. There are five successful, published
cases of the use of the ChR2 BAC transgenic approach; these
used vesicular glutamate transporter 2 (vGluT2) (Ha¨gglund
et al., 2010), vesicular gamma aminobutyric acid (GABA) trans-
porter (VGAT), choline acethyltransferase (ChAT), tryptophan
hydroxylase-2 (Tph2), and parvalbumin, (Pvalb) (Zhao et al.,
2011) promoters. In all cases, expression of the mRNAs encod-
ing these proteins is high, indicating that these promoters have
very strong activity. If cell type-specific marker gene expression
were weak, the BAC transgenic strategy may not achieve
enoughChR2 expression for optogeneticmanipulation, although404 Cell Reports 2, 397–406, August 30, 2012 ª2012 The Authorsother strategies could be sought in addition to the BAC strategy
to compensate for the weak promoter activity.
The advantage of the Cre-loxP and tet system-mediated strat-
egies is that a panel of cell type-specific Cre and tTA lines
already exists. Both systems are also equipped with gene ampli-
fication modules. The Cre-loxP system utilizes the CMV early
enhancer/chicken b-actin (CAG) promoter in the ROSA locus,
and the tet system utilizes the tTA-dependent promoter; both
promoters can strongly drive gene induction. One drawback of
the Cre-loxP system is that it has been reported that even with
the ChR2 transgene located at the ROSA locus with the CAG
promoter, homozygosity was required to induce sufficient
expression of ChR2 to drive action potential firing specifically
in cortical interneurons (Ka¨tzel et al., 2011). That being said,
both the Cre-loxP and tet systems are ideal in achieving both
specificity and amplification of ChR2 expression. Our choice of
the modified ChR2(C128S) as a target transgene was also
advantageous for optogenetic control of cell activity because
of the higher sensitivity to light and the shorter illumination time
required for long-term ChR2 activation.
As shown in this study, our KENGE-tet system is applicable to
optogenetic manipulation of not only excitable neurons but also
‘‘nonexcitable’’ glial cells. We demonstrated that ChR2(C128S)-
mediated inward currents resulted in c-fos mRNA induction in
astrocytes.We also observed c-fosmRNA induction in oligoden-
drocytes in PLP-tTA::tetO-ChR2(C128S)-EYFP knockin mice
after illumination (data not shown). These results indicate that
ChR2(C128S) activation can be used as a tool to change the
status of nonexcitable cells and that the change in their activity
can be traced by c-fos induction.
Optogenetic manipulation of nonexcitable cells outside the
nervous system could also be used to understand cell type-
specific functionality in various tissues. For example, we
have noticed that tissue macrophages—osteoclasts in bone,
Kupffer cells in liver, and alveolar macrophages in lung—all
express ChR2(C128S)-EYFP in Iba1-tTA::tetO-ChR2(C128S)-
EYFP knockin mice (data not shown). For driving the activity
of these nonexcitable cells, in addition to ChR2(C128S), Ca2+-
permeable ChR2 (Kleinlogel et al., 2011) could be used
for Ca2+ induction and photoactivated adenylate cyclase
(Schro¨der-Lang et al., 2007) could be used for cAMP induction.
Construction of a panel of tetO knockin lines, including the
above-mentioned light-sensitive proteins, will add options for
optogenetic manipulation of cell function in both excitable and
nonexcitable cells and facilitate research in many fields.
EXPERIMENTAL PROCEDURES
Generation of Transgenic Mice
Detailed information of generating tetO-ChR2(C128S)-EYFP BAC transgenic
mice, tetO-ChR2(C128S)-EYFP knockin mouse, Iba1-tTA mouse, Htr5B-tTA
mouse, and GAD67-tTA mouse is available in the Extended Experimental
Procedures. A schematic diagram indicating the targeting vector for tetO-
ChR2(C128S)-EYFP is given in Figure S1. Basic characterization of Iba1-tTA
and Htr5B-tTA mice is shown in Figures S2 and S3. Information regarding
aCaMKII-tTA (Mayford et al., 1996), BTR6 (Chuhma et al., 2011), Mlc1-tTA
(Tanaka et al., 2010), and PLP-tTA (Inamura et al., 2012) mice are already
published. Information regarding Orexin-tTA mouse (generated by A.Y.)
is unpublished. Genotyping primers are also given in the Extended Experi-
mental Procedures.
Immunohistochemistry and In Situ Hybridization
Standard procedures were taken for immunohistochemistry and the
antibodies used and the reaction times are given in detail in the Extended
Experimental Procedures. The in situ hybridization method was as described
previously (Ma et al., 2006) and written briefly in the Extended Experimental
Procedures.
Acute Brain Slice Preparations and Patch-Clamp Recordings
Brain slices were prepared from mice aged P14–P21, unless otherwise
noted. Slices were cut at a thickness of 250–400 mm using a microslicer and
the slices were transferred to a submerged-type recording chamber and
continuously superfused. All recordings were performed at room temperature
(22–25C). Visually identified cells were voltage clamped at –70 mV in
whole-cell patch clamp mode. High-power blue LED (470 nm; 8 mW at
sample location) was placed underneath the condenser lens of the upright
microscope for full-field activation of ChR2(C128S) and yellow light, filtered
(560 nm center 14 nm band-pass filter; 0.15 mW at sample location) from a
mercury lamp, was directed through the epifluorescence port for closing of
the ChR2(C128S).
In Vivo Electrophysiological Recording and Optical Stimulation
Each mouse was anesthetized with ketamine hydrochloride (100 mg/kg body
weight, i.p.) and xylazine hydrochloride (5 mg/kg body weight, i.p.). The skull
was widely exposed and a small U-frame holder was attached for head fixa-
tion. After recovery from the surgery (2 or 3 days later), the mouse was posi-
tioned in a stereotaxic apparatus with its head restrained using the U-frame
holder under light anesthesia with ketamine hydrochloride (50–100 mg/kg
bodyweight, i.p.). A part of the skull in one hemisphere was removed to access
the hippocampus. For recording neural activity while illuminating with blue
light, a glass-coated Elgiloy microelectrode (0.5–1.0 MU at 1 kHz), along
with a 50 mm diameter optical fiber, was inserted perpendicularly into the brain
through the dura mater using a hydraulic microdrive. A 50 mW blue laser was
coupled to an optical fiber. The target area was 2.0–3.0 mm posterior and 1.5–
3.0 mm lateral to bregma and 1.2–1.6 mm deep from the brain surface for the
hippocampus (Franklin and Paxinos, 2008).
In Vivo Optical Stimulation in Freely Moving Mice
Violet light was generated by laser diode (445 nm, 400 mW) and applied
through plastic optical fibers (0.5 mm diameter). An optical swivel (COME2,
Lucir, Tsukuba, Japan) was used for unrestricted in vivo illumination. Violet
light power intensity at the tip of the plastic fiber was 6.7 mW/mm2. For
hippocampal CA1 pyramidal neuron stimulation, a plastic optical fiber was
inserted above the left dorsal hippocampus using a stereotaxic frame with
the tip of the fiber located at 2.0 mm posterior, 1.5 mm lateral to bregma,
and 1 mm deep from the skull. The fiber was fixed on the skull using dental
cement. For astrocyte stimulation, the plastic fiber was placed on top of
the skull (0.5 mm anterior and 1.5 mm lateral to bregma) and fixed with the
dental cement. The mice were allowed to recover for at least one week
after fiber implantation. For hippocampal neuron stimulation, 500 ms illumina-
tion was given every 1 min in the home cage, and locomotive activity was
captured with a video camera. For astrocyte stimulation, 500 ms illumination
was given every 10 s in the home cage. Details for all physiological and
behavioral experiments are also described in the Extended Experimental
Procedures.
Resource
tetO-ChR2(C128S)-EYFP BAC transgenic (Reference number: RBRC05453),
tetO-ChR2(C128S)-EYFP knockin (RBRC05454), Mlc1-tTA(RBRC05450), PLP-
tTA (RBRC05446), and Htr5B-tTA (RBRC05445) are available from RIKEN
Bioresource Center in Japan.
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